In vitro experiments indicated that PD-L2 knockdown attenuated tumor growth and metastasis by inhibiting the RhoA-ROCK-LIMK2 pathway and autophagy (Ren et al., 2019). The gene discussed is PDCD1LG2; the disease is neoplasm.